The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Synaptic alterations in the rTg4510 mouse model of tauopathy
Abstract
Synapse loss, rather than the hallmark amyloid‐β (Aβ) plaques or tau‐filled neurofibrillary tangles (NFT), is considered the most predictive pathological feature associated with cognitive status in the Alzheimer's disease (AD) brain. The role of Aβ in synapse loss is well established, but despite data linking tau to synaptic function, the role of tau in synapse loss remains largely undetermined. Here we test the hypothesis that human mutant P301L tau overexpression in a mouse model (rTg4510) will lead to age‐dependent synaptic loss and dysfunction. Using array tomography and two methods of quantification (automated, threshold‐based counting and a manual stereology‐based technique) we demonstrate that overall synapse density is maintained in the neuropil, implicating synapse loss commensurate with the cortical atrophy known to occur in this model. Multiphoton in vivo imaging reveals close to 30% loss of apical dendritic spines of individual pyramidal neurons, suggesting these cells may be particularly vulnerable to tau‐induced degeneration. Postmortem, we confirm the presence of tau in dendritic spines of rTg4510‐YFP mouse brain by array tomography. These data implicate tau‐induced loss of a subset of synapses that may be accompanied by compensatory increases in other synaptic subtypes, thereby preserving overall synapse density. Biochemical fractionation of synaptosomes from rTg4510 brain demonstrates a significant decrease in expression of several synaptic proteins, suggesting a functional deficit of remaining synapses in the rTg4510 brain. Together, these data show morphological and biochemical synaptic consequences in response to tau overexpression in the rTg4510 mouse model. J. Comp. Neurol., 521:1334–1353, 2013. © 2012 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“rTg4510 mice recapitulate aspects of human tauopathy including but not limited to gliosis, neuronal loss, tau tangle formation, and transposable element activation (17–20).”
From Pathogenic tau–induced transposable element–derived dsRNA drives neuroinflammation (2023) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Self-citationSynapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821 · cited 4×
“The synapse, however, has been proposed as a point of convergence for both Ab and tau toxicity (Ittner et al., 2010; Roberson et al., 2011).”
BackgroundInfluentialAlzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758 · cited 2×
“…mislocalization of PSD95, which serves as a scaffold for essential postsynaptic elements such as NMDA and AMPA receptors, may have negative ramifications for their localization or function as well (Hoover et al., 2010; Chakroborty and Stutzmann, 2011; D’Amelio et al., 2011; Huang and Mucke, 2012).”
BackgroundNeuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489
Self-citationPropagation of Tau Pathology in a Model of Early Alzheimer's Disease
de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427
Self-citationTangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease
Giannakopoulos, P., Herrmann, F. R., Bussière, T., Bouras, C., Kövari, E., Perl, D. P., Morrison, J. H., Gold, G., & Hof, P. R. (2003) · Neurology · doi:10.1212/01.wnl.0000063311.58879.01 · Cited by 1,118 · cited 3×
“…are deposits of amyloid-b (Ab), the peptide largely considered the initiator of the disease (Hardy and Selkoe, 2002), and yet amyloid burden does not correlate well with synapse and neuronal loss or severity of AD (Arriagada et al., 1992; Giannakopoulos et al., 2003; Ingelsson et al., 2004).”
BackgroundHoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., Pitstick, R., Carlson, G. A., Lanier, L. M., Yuan, L.-L., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.030 · Cited by 1,118
Self-citation
Research works printed but not linked: 43
- 10.1016/j.nbd.2011.10.022 · DOI
- 10.3233/JAD-2010-100120 · DOI
- 10.1523/JNEUROSCI.5425-05.2006 · DOI · Paper page
- 10.1074/jbc.271.51.32789 · DOI · Paper page
- 10.1007/s11427-011-4205-7 · DOI
- 10.1007/s00401-011-0877-0 · DOI
- 10.1096/fj.08-109181 · DOI · Paper page
- Davies P, 2000, Characterization and use of monoclonal antibodies to tau and paired helical filament tau, Methods Mol Med, 32, 361
- 10.1007/s00429-010-0245-1 · DOI
- 10.1002/cm.20243 · DOI
- 10.1016/0168-0102(86)90062-3 · DOI
- 10.1126/science.4071042 · DOI · Paper page
- 10.1073/pnas.87.15.5827 · DOI · Paper page
- 10.1016/S0021-9258(18)48531-6 · DOI · Paper page
- 10.1111/j.1699-0463.1988.tb00954.x · DOI · Paper page
- Hall GF, 2000, Human tau filaments induce microtubule and synapse loss in an in vivo model of neurofibrillary degenerative disease, J Cell Sci, 113, 1373, 10.1242/jcs.113.8.1373 · DOI
- 10.1126/science.1072994 · DOI · Paper page
- 10.1002/ana.410230410 · DOI · Paper page
- 10.1016/j.ajpath.2011.06.025 · DOI
- 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E · doi:10.1002/(sici)1097-4547(19970415)48:2<128::aid-jnr5>3.0.co;2-e
- 10.1074/jbc.M110.136630 · DOI
- 10.1093/jnen/61.9.797 · DOI · Paper page
- 10.1016/j.ajpath.2011.07.004 · DOI · Paper page
- 10.1523/JNEUROSCI.4859-11.2011 · DOI
- 10.1016/j.nbd.2008.02.012 · DOI
- 10.1016/j.neuron.2010.09.024 · DOI · Paper page
- 10.1523/JNEUROSCI.2824-07.2008 · DOI · Paper page
- 10.1523/JNEUROSCI.3463-09.2009 · DOI · Paper page
- 10.1002/cne.20468 · DOI
- 10.1016/S0959-4388(00)00218-X · DOI · Paper page
- 10.1126/science.1113694 · DOI · Paper page
- 10.1016/j.neurobiolaging.2003.08.002 · DOI · Paper page
- 10.1523/JNEUROSCI.4245-05.2006 · DOI · Paper page
- 10.1155/2012/319836 · DOI · Paper page
- 10.1523/JNEUROSCI.3072-08.2008 · DOI · Paper page
- 10.1083/jcb.200108057 · DOI · Paper page
- 10.1007/s12031-011-9604-5 · DOI
- 10.1016/j.ajpath.2012.06.033 · DOI · Paper page
- 10.1109/83.650848 · DOI · Paper page
- 10.1016/0006-8993(88)91114-6 · DOI
- 10.1126/science.3083509 · DOI · Paper page
- 10.1523/JNEUROSCI.0227-12.2012 · DOI
- 10.1155/2012/247150 · DOI
Cited by
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease
Spires-Jones, T. L., & Hyman, B. T. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.004 · Cited by 1,201
Self-citationSynaptic degeneration in Alzheimer disease
Tzioras, M., McGeachan, R. I., Durrant, C. S., & Spires-Jones, T. L. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-022-00749-z · Cited by 504
Self-citationZhang, Y.-H., Wang, D.-W., Xu, S.-F., Zhang, S., Fan, Y.-G., Yang, Y.-Y., Guo, S.-Q., Wang, S., Guo, T., Wang, Z.-Y., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2017.11.001 · Cited by 304
Role of tau protein in Alzheimer’s disease: The prime pathological player
Muralidar, S., Ambi, S. V., Sekaran, S., Thirumalai, D., & Palaniappan, B. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.327 · Cited by 278
Alzheimer's disease and type 2 diabetes: a critical assessment of the shared pathological traits
Chatterjee, S., & Mudher, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00383 · Cited by 270
Metadata
- Authors
- Kopeikina, K. J., Polydoro, M., Tai, H., Yaeger, E., Carlson, G. A., Pitstick, R., Hyman, B. T., & Spires‐Jones, T. L.
- Venue
- Journal of Comparative Neurology
- Publisher
- Wiley
- Published
- 2013-02-20
- Volume
- 521
- Issue
- 6
- Pages
- 1334-1353
- ISSN
- 0021-9967
- 1096-9861
- PMC
- PMC3725804
- Cited by
- 118
- References
- 45
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Synaptic alterations in the rTg4510 mouse model of tauopathy. https://app.cochat.ai/papers/10.1002/cne.23234
- The paper
- Kopeikina, K. J., Polydoro, M., Tai, H., Yaeger, E., Carlson, G. A., Pitstick, R., Hyman, B. T., & Spires‐Jones, T. L. (2013). Synaptic alterations in the rTg4510 mouse model of tauopathy. Journal of Comparative Neurology. https://doi.org/10.1002/cne.23234
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.